BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

Multiple myeloma (MM) evolves from a premalignant condition known as monoclonal gammopathy of undetermined significance (MGUS). However, the factors underlying the malignant transformation of plasmocytes in MM are not fully characterized. We report here that Eµ-directed expression of the antiapoptot...

Full description

Bibliographic Details
Main Author:	Fenouille, Nina
Other Authors:	Koch Institute for Integrative Cancer Research at MIT
Format:	Article
Language:	en_US
Published:	Rockefeller University Press 2017
Online Access:	http://hdl.handle.net/1721.1/107131

Similar Items

NSO myeloma cell death: Influence of bcl-2 overexpression.
by: Murray, K, et al.
Published: (1996)

Correlation of c-MYC, BCL2 and BCL6 proteins overexpression with prognosis in Syrian DLBCL Patients
by: Sulaf Ahmad Farhat Maghrabi, et al.
Published: (2024-09-01)

BCL2 overexpression in diffuse large B-cell Lymphoma
by: Hajar Masrour, et al.
Published: (2023-01-01)

Effect of Bcl-2 overexpression on cell cycle and antibody productivity in chemostat cultures of myeloma NS0 cells
by: Tey, Beng Ti, et al.
Published: (2005)

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
by: Jennifer K. Lue, et al.
Published: (2024-10-01)

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
by: Vijay G. Ramakrishnan, et al.
Published: (2019-10-01)

P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.
by: Cristina De Ramón Sánchez, et al.
Published: (2023-08-01)

The impact of bcl-2 overexpression on product MAb glycosylation in hybridoma cultures /
by: 281866 Fadzilah Adibah Abd. Majid, et al.
Published: (2003)

Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients
by: Cristina De Ramón, et al.
Published: (2024-12-01)

A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma
by: Yutaka Tsutsumi, et al.
Published: (2022-01-01)

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS
by: Annita-Ioanna Gkioka, et al.
Published: (2023-08-01)

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
by: Daria Galas-Filipowicz, et al.
Published: (2024-04-01)

Carrageenan-Induced Colonic Inflammation Is Reduced in Bcl10 Null Mice and Increased in IL-10-Deficient Mice
by: Sumit Bhattacharyya, et al.
Published: (2013-01-01)

P860: CIRCULATING MULTIPLE MYELOMA CELLS (CMMCS) AS PROGNOSTIC FACTOR AND MINIMAL RESIDUAL DISEASE MARKER IN MM AND SMOULDERING MM PATIENTS
by: Ilaria Vigliotta, et al.
Published: (2023-08-01)

Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients
by: Manuel Beltrán‐Visiedo, et al.
Published: (2023-12-01)

Association between BCL2 interacting protein 3 like (BNIP3L) genetic polymorphisms and the risk of multiple myeloma in China
by: Qicai Wang, et al.
Published: (2024-12-01)

Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)
by: Jun Du, et al.
Published: (2024-03-01)

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
by: Esperanza M Algarín, et al.
Published: (2020-03-01)

Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
by: Anja Schneller, et al.
Published: (2021-04-01)

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma
by: Vivian Zhou, et al.
Published: (2024-07-01)

Mutations in Bcl10 are very rare in colorectal cancer.
by: Stone, J, et al.
Published: (1999)

Ascorbic Acid Augments Arsenic-Mediated Cell Death in Multiple Myeloma (MM) Cells
by: Jennifer M. Grad, et al.
Published: (2001-01-01)

P1685: PATIENTS’ PREFERENCES FOR MULTIPLE MYELOMA (MM) TREATMENT INITIATION AND DISCONTINUATION IN THE US
by: Adam F. Binder, et al.
Published: (2023-08-01)

Mechanical properties of 10mm single sized porous concrete with 5mm aggregate /
by: Saleha Mohd. Yusoff, 1986-, et al.
Published: (2009)

P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM
by: Gil Fridberg, et al.
Published: (2023-08-01)

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
by: Atenea A. Perez-Serna, et al.
Published: (2025-01-01)

Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01)

UBQLN4 is an ATM substrate that stabilizes the anti‐apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma
by: Fang Liu, et al.
Published: (2021-12-01)

B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2
by: Ingrid G. Winkler, et al.
Published: (2013-03-01)

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
by: Rodrigo Fonseca, et al.
Published: (2025-02-01)

Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
by: Foight, Glenna W., et al.
Published: (2017)

IN VIVO ENRICHMENT OF REGULATORY T CELLS BY BCL-2/BCL-XL INHIBITION PROMOTES TOLERANCE IN ALLOTRANSPLANTATION
by: Gabriel, S, et al.
Published: (2013)

Correlation between Bcl-2 Expression and the Efficacy of Bcl-2 Inhibitors in Patients with Myelodysplastic Syndromes
by: WU Jiafei, WANG Jun, WANG Yijing, ZHENG Boyue, WANG Yu, JIANG Chuanyan, DONG Dandan, LI Hui
Published: (2024-06-01)

BCL-XL regulates the timing of mitotic apoptosis independently of BCL2 and MCL1 compensation
by: Chun Yin Yu, et al.
Published: (2024-01-01)

Synchronous Occurrence of Splenic Pleomorphic Mantle Cell Lymphoma and Esophageal Adenocarcinoma with Overexpression of BCL1 Protein
by: Dominik Dabrowski, et al.
Published: (2020-01-01)

Bcl-2 Overexpression Improves Survival and Efficacy of Neural Stem Cell-Mediated Enzyme Prodrug Therapy
by: Rachael Mooney, et al.
Published: (2018-01-01)

Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.
by: Liu, H, et al.
Published: (2006)

Mechanical properties of 10mm single sized porous concrete with 5mm aggregate [electronic resource] /
by: 341038 Saleha Mohd. Yusoff, et al.
Published: (2009)

Fresh and Hardened Properties of Brick Aggregate Concrete with Maximum Aggregate Sizes of 10 mm to 75 mm
by: Tarek Uddin Mohammed, et al.
Published: (2023-09-01)

35mm and 16mm microfilms, spools and reels
by: 8096 British Standards Institution